Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soneira is a neurotechnology company focused on developing next-generation, non-invasive brain-sensing hardware. The company's core technology leverages high-performance magnetic sensors to detect neural activity with high spatial and temporal resolution, bypassing the need for invasive surgical implants. By miniaturizing and enhancing the sensitivity of these sensors, Soneira aims to transition magnetoencephalography (MEG) from large, expensive room-sized machines to portable, wearable formats. This platform has the potential to revolutionize clinical diagnostics for neurological disorders and enable advanced human-computer interaction. The company is currently in the research and development phase, refining its sensor technology for broad medical and consumer applications. Soneira's approach seeks to provide the high-fidelity data of invasive electrodes with the safety and ease of a wearable device.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soneira.